ul. 20 Pre-market Movers Board: Tesla drops 4% premarket as Q2 gross profit fell to 18.2% from 25% y/y

Seize the market opportunities with us at 8:45 every morning, and don't forget to check our ‘Lunchtime Movers Board’ at 12:00.

Premarket Gainers: PainReform, BioSig, Eliem, Nanobiotix, Bright Minds

PRFX:

PainReform surges 40% premarket after re-compliant with Nasdaq’s continuous listing requirements.

BSGM:

BioSig Technologies climbs 16% premarket after its subsidiary was selected to join NVIDIA Inception.

ELYM:

Eliem Therapeutics spikes 12% after saying it would end further development of its Kv7 pipeline program and explore its strategic alternatives.

NBTX:

Nanobiotix climbs 9% premarket after announcing first patient injected in new Phase 1/2 study evaluating radiotherapy.

DRUG:

Bright Minds Biosciences shares up 8% premarket after announcing positive topline data for its first in human phase 1 study.

Premarket Losers: Netcapital, Richardson, Infosys, Netflix, Tesla

NCPL:

Netcapital slumps 43% after pricing its public offering of 1.725M shares at $0.70/Shr.

RELL:

Richardson Electronics drops 9% premarket as Q4 EPS $0.11 missed $0.19 estimate.

INFY:

Infosys drops 7% premarket after cutting revenue growth outlook.

NFLX:

Netflix drops 6% premarket as Q2 guidelines fell short of expectations.

TSLA:

Tesla drops 4% premarket as Q2 gross profit fell to 18.2% from 25% y/y.

$PRFX(PRFX)$BSGM(BSGM)$ELYM(ELYM)$NBTX(NBTX)$DRUG(DRUG)$NCPL(NCPL)$RELL(RELL)$INFY(INFY)$NFLX(NFLX)$TSLA(TSLA)